We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study!This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our…— Neuralink (@neuralink) May 25, 2023
Imagine allowing a private corporation to implant a proprietary technology in your soul-jello.
There will eventually be companies that require it for all their employees.